AbbVie develops and sells prescription medicines. Its work centres on immunology, with Skyrizi and Rinvoq, along with neuroscience, oncology and eye care, and its Allergan Aesthetics arm makes Botox and dermal fillers. AbbVie came into being in 2013 when Abbott Laboratories separated its research-based pharmaceutical business, and it absorbed Allergan in 2020. Its older medicine Humira treats conditions like rheumatoid arthritis, psoriasis and Crohn's disease, and many biosimilar versions now compete with it.
AbbVie Inc. is listed on the New York Stock Exchange under the ticker ABBV. It is part of the Healthcare sector, in the Drug Manufacturers - General industry, and is based in North Chicago, United States.
This page opens SwinGrowth's analysis of AbbVie from its real daily price history: an entry zone, a stop loss and two price targets for a swing trade, with its trend, RSI, moving averages, volume, support and resistance.
Other Healthcare stocks on SwinGrowth: Johnson & Johnson, Merck and UnitedHealth.
Education, not financial advice. SwinGrowth does not predict prices or tell you to buy or sell.